(Q39791492)

14 September 2017

SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells (English)

1 reference

14 September 2017

1 reference

2

1 reference

14 September 2017

8

1 reference

14 September 2017

Marcello Persico

1

1 reference

14 September 2017

Eliana Persico

3

1 reference

14 September 2017

Monica Svelto

4

1 reference

14 September 2017

Daniela Spano

5

1 reference

14 September 2017

Immacolata Andolfo

6

1 reference

14 September 2017

Vincenzo La Mura

7

1 reference

14 September 2017

Claudio Tiribelli

9

1 reference

14 September 2017

Roberto Torella

10

1 reference

14 September 2017

Achille Iolascon

11

1 reference

14 September 2017

1 January 2009

1 reference

Clinical Chemistry and Laboratory Medicine

14 September 2017

1 reference

14 September 2017

47

1 reference

14 September 2017

10

1 reference

14 September 2017

1217-1225

1 reference

Hepatitis C virus infection

14 September 2017

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Antiviral treatment of hepatitis C: present status and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus-related chronic hepatitis: Insulin resistance and response to antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Hepatitis C Virus Replication in Transfected and Serum-Infected Cultured Human Fetal Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Typing of hepatitis C virus isolates by DNA enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Alpha Interferon Inhibits Hepatitis C Virus Replication in Primary Human Hepatocytes Infected In Vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Avoiding false positives with PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Investigation into the ability of GB virus B to replicate in various immortalized cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Complete replication of hepatitis C virus in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

Replication of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.280

21 January 2018

Identifiers

DOI

10.1515/CCLM.2009.280

1 reference

14 September 2017

1 reference